| Effik SA - Cariban 10 mg/10 mg, gélule à libération modifiée | | 67670 | | 01 | | Cariban 10 mg/10 mg | | gélule à libération modifiée | | R06AA59 | | | | 12.11.2020 | | |
| | Composition | | doxylamini hydrogenosuccinas 10 mg corresp. doxylaminum 7 mg, pyridoxini hydrochloridum 10 mg corresp. pyridoxinum 8.2 mg, sacchari sphaerae corresp. saccharum 49.3 - 73.1 mg, talcum, silica colloidalis anhydrica, matériel de la capsule: lacca, povidonum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, gelatina, E 132, E 104, E 171, pro capsula. | | Packungsbestandteile | | | | | | | Principe actif | Concentr. |
|---|
| Doxylamine Hydrogenosuccinate | 10 mg correspond Doxylamine 7 mg | | Pyridoxine Hydrochloride | 10 mg correspond Pyridoxine 8.2 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Doxylamine Hydrogenosuccinate | 10 mg | | Pyridoxine Hydrochloride | 10 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| | | | | | | color. | | | | color. | | | | color. | | Gelatina | | | | | | matériel de la capsule | | | | | | Povidone | | | | | | | | | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| |
|
